Hofseth Biocare ASA
Research Hofseth Biocare ASA (HBC) on Bullrun: market cap NOK 552.30M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHBC
- ExchangeOL
- CountryNorway
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyNOK
- Market capNOK 552.30M
- Financial periodFY2024
- RevenueNOK 256.83M
- Revenue growth34.6%
- Net income-NOK 125.30M
- Free cash flow-NOK 12.22M
- Gross margin34.0%
Valuation Snapshot
latest market cap is NOK 552.30M.
About Hofseth Biocare ASA
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein.
Frequently asked questions
What is Hofseth Biocare ASA's market cap?
Hofseth Biocare ASA's market capitalization is NOK 552.30M.
What does Hofseth Biocare ASA do?
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health;